Genetesis, Inc.
- Country
- ๐บ๐ธUnited States
- Ownership
- Holding
- Established
- 2013-09-05
- Employees
- 11
- Market Cap
- -
- Website
- http://www.genetesis.com
Clinical Trials
13
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)
- Conditions
- Myocardial IschemiaIschemic Heart DiseaseAnginaCoronary Microvascular Disease
- First Posted Date
- 2024-01-18
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- Genetesis Inc.
- Target Recruit Count
- 136
- Registration Number
- NCT06212466
- Locations
- ๐บ๐ธ
University of Florida, Division of Cardiovascular Medicine, Gainesville, Florida, United States
๐บ๐ธSaint Elizabeth Medical Center, Edgewood, Kentucky, United States
๐บ๐ธAscension St. John Hospital, Detroit, Michigan, United States
MCG for Suspected INOCA Confirmed by Thermodilution-Derived CFR
- Conditions
- AnginaIschemic Heart DiseaseCoronary Microvascular Disease
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Genetesis Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT06139094
- Locations
- ๐บ๐ธ
University of Florida, Gainesville, Florida, United States
๐บ๐ธAscension St. John Hospital, Detroit, Michigan, United States
๐บ๐ธThe Christ Hospital, Cincinnati, Ohio, United States
A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients with Suspected Coronary Ischemia.
- Conditions
- Coronary; Ischemic
- First Posted Date
- 2023-05-22
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- Genetesis Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT05868902
- Locations
- ๐บ๐ธ
Cleveland Clinic, Cleveland, Ohio, United States
๐บ๐ธKettering Health, Kettering, Ohio, United States
Magnetocardiography as a Noninvasive Diagnostic Strategy for Identifying Coronary Allograft Vasculopathy
- Conditions
- Coronary Allograft Vasculopathy (CAV)
- First Posted Date
- 2023-03-02
- Last Posted Date
- 2023-07-11
- Lead Sponsor
- Genetesis Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT05751915
- Locations
- ๐บ๐ธ
The Cleveland Clinic, Cleveland, Ohio, United States
MCG as a Noninvasive Diagnostic Strategy for Suspected Coronary Microvascular Dysfunction
- Conditions
- Ischemic Non-Obstructive Coronary Artery DiseaseCoronary Microvascular Dysfunction
- First Posted Date
- 2021-12-08
- Last Posted Date
- 2023-08-31
- Lead Sponsor
- Genetesis Inc.
- Target Recruit Count
- 93
- Registration Number
- NCT05150054
- Locations
- ๐บ๐ธ
Ascension St. John, Detroit, Michigan, United States
๐บ๐ธThe Christ Hospital, Cincinnati, Ohio, United States
๐บ๐ธCleveland Clinic, Cleveland, Ohio, United States
- Prev
- 1
- 2
- 3
- Next